VeriMomelaidoyl tripeptide-37 est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive/toxicity studies located for elaidoyl tripeptide‑37 in the referenced databases. No specific evidence of reproductive toxicity or endocrine activity was identified (sources searched: ECHA Annex VI, SCCS, CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG). Given the lack of data and absence of regulatory flags, default hazard and mechanism scores are 0.
Related ingredients
Frequently asked questions
- elaidoyl tripeptide-37 est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive/toxicity studies located for elaidoyl tripeptide‑37 in the referenced databases. No specific evidence of reproductive toxicity or endocrine activity was identified (sources searched: ECHA Annex VI, SCCS, CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG). Given the lack of data and absence of regulatory flags, default hazard and mechanism scores are 0.
- elaidoyl tripeptide-37 est-il sûr pendant l'allaitement ?
- No data on lactation transfer or effects on breastfed infants were identified in authoritative sources. No regulatory or peer‑reviewed signals indicating risk; therefore hazard and mechanism scored 0. Exposure for breastfeeding considered comparable to maternal topical exposure (no data to indicate high systemic availability).
- elaidoyl tripeptide-37 est-il sûr pour la peau de bébé ?
- No infant‑specific safety data found. As a peptide acylated with an elaidoyl (fatty) group, molecular size and polarity suggest limited dermal absorption in adults, but infant skin has higher permeability; following the guidance, exposure score increased by +1 for 0–3 yr skin despite no evidence of hazard/mechanism. No data show increased infant hazard or specific mechanisms.
- Comment VeriMom évalue-t-il elaidoyl tripeptide-37 ?
- VeriMom évalue elaidoyl tripeptide-37 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à elaidoyl tripeptide-37 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à elaidoyl tripeptide-37 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.